Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]AOP Orphan Pharmaceuticals AG"
Count: 16
Selected: 0
NCT IDTitle
NCT06350032Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
NCT06317805Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
NCT02218047AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
NCT01193699Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera
NCT01949805Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
NCT01230775Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
NCT02523638Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients
NCT02076815Anagrelide Retard in Essential Thrombocythemia
NCT01741519Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers
NCT01652898A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers
NCT01313143A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol
NCT01065038Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia
NCT00671736Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis
NCT03003325The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV
NCT01933906Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response
NCT03117816ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission